Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide and few drugs are available for its treatment. Lycorine has effective anti-inflammatory and lipid-lowering effects, but the impact on MASLD is not fully understood. In this...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2024-11-01
|
| シリーズ: | Molecular Medicine |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s10020-024-01003-6 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
